Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if 5-azacitidine and sorafenib can
control the disease in patients with AML or MDS. The safety of this drug combination will
also be studied.